AT476985T
Platelet-derived growth factor compositions and methods of use thereof
Abstract
A promoter of bone, periodontal tissue, ligament or cartilage growth method in a mammal, the method through the bone, periodontal tissue, ligament or cartilage administering a composition, the composition in a pharmaceutically acceptable liquid carrier and drug acceptable solid carrier comprises about 0.1mg / mL to about 1.0mg / mL range of concentrations of platelet-derived growth factor.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
113 members in 20 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 96531904 | United States of America | A | |
| 15953305 | United States of America | A | |
| 2005036447 | United States of America | W |
Members113
| Document | Office | Kind | |
|---|---|---|---|
| US2006084602A1 | United States of America | A1 | |
| AU2005295919A1 | Australia | A1 | |
| CA2583823A1 | Canada | A1 | |
| CA2726144A1 | Canada | A1 | |
| WO2006044334A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2006318689A1 | Australia | A1 | |
| CA2630077A1 | Canada | A1 | |
| WO2007061889A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2007129807A1 | United States of America | A1 | |
| NO20071974L | Norway | L | |
| IL182480D0 | Israel | D0 | |
| EP1812076A2 | European Patent Office (EPO) | A2 | |
| MX2007004459A | Mexico | A | |
| AU2007212273A1 | Australia | A1 | |
| CA2641860A1 | Canada | A1 | |
| WO2007092622A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2007207185A1 | United States of America | A1 | |
| KR20070095288A | Republic of Korea | A | |
| WO2007092622A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2007259814A1 | United States of America | A1 | |
| WO2006044334A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2007061889A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2008516675A | Japan | A | |
| CN101198343A | China | A | |
| EP1951327A2 | European Patent Office (EPO) | A2 | |
| NO20082393L | Norway | L | |
| BRPI0516105A | Brazil | A | |
| KR20080084808A | Republic of Korea | A | |
| EP1812076A4 | European Patent Office (EPO) | A4 | |
| ZA200703515B | South Africa | B | |
| EP1991282A2 | European Patent Office (EPO) | A2 | |
| AU2008259785A1 | Australia | A1 | |
| CA2689986A1 | Canada | A1 | |
| WO2008151193A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US7473678B2 | United States of America | B2 | |
| CN101370531A | China | A | |
| US2009074753A1 | United States of America | A1 | |
| AU2005295919B2 | Australia | B2 | |
| JP2009515668A | Japan | A | |
| AU2009202532A1 | Australia | A1 | |
| HK1125868A1 | Hong Kong, China | A1 | |
| JP2009195739A | Japan | A | |
| US2010183515A1 | United States of America | A1 | |
| NZ554511A | New Zealand | A | |
| EP1812076B1 | European Patent Office (EPO) | B1 | |
| AT476985TThis record | Austria | T | |
| ATE476985T1 | Austria | T1 | |
| CN101820895A | China | A | |
| EP2223698A1 | European Patent Office (EPO) | A1 | |
| US7799754B2 | United States of America | B2 | |
| DE602005022911D1 | Germany | D1 | |
| ES2346457T3 | Spain | T3 | |
| DK1812076T3 | Denmark | T3 | |
| PT1812076E | Portugal | E | |
| KR20110013492A | Republic of Korea | A | |
| CA2583823C | Canada | C | |
| EP2308500A1 | European Patent Office (EPO) | A1 | |
| EP2308501A1 | European Patent Office (EPO) | A1 | |
| EP2311505A1 | European Patent Office (EPO) | A1 | |
| US2011117018A1 | United States of America | A1 | |
| BRPI0618794A2 | Brazil | A2 | |
| US8114841B2 | United States of America | B2 | |
| NZ571113A | New Zealand | A | |
| ZA200804548B | South Africa | B | |
| EP2431060A2 | European Patent Office (EPO) | A2 | |
| US2012128774A1 | United States of America | A1 | |
| AU2009202532B2 | Australia | B2 | |
| NZ582976A | New Zealand | A | |
| EP2431060A3 | European Patent Office (EPO) | A3 | |
| JP5137577B2 | Japan | B2 | |
| KR20130058762A | Republic of Korea | A | |
| EP1991282B1 | European Patent Office (EPO) | B1 | |
| KR101305922B1 | Republic of Korea | B1 | |
| AU2007212273B2 | Australia | B2 | |
| ES2427993T3 | Spain | T3 | |
| EP2311505B1 | European Patent Office (EPO) | B1 | |
| JP5368102B2 | Japan | B2 | |
| EP2308500B1 | European Patent Office (EPO) | B1 | |
| ES2443581T3 | Spain | T3 | |
| ES2454841T3 | Spain | T3 | |
| AU2008259785B2 | Australia | B2 | |
| IL182480A | Israel | A | |
| CA2630077C | Canada | C | |
| CA2726144C | Canada | C | |
| CA2641860C | Canada | C | |
| US9161967B2 | United States of America | B2 | |
| US2016000972A1 | United States of America | A1 | |
| EP2308501B1 | European Patent Office (EPO) | B1 | |
| CN105561384A | China | A | |
| BRPI0516105B1 | Brazil | B1 | |
| EP2223698B1 | European Patent Office (EPO) | B1 | |
| US2016310639A1 | United States of America | A1 | |
| CN106110299A | China | A | |
| US9545377B2 | United States of America | B2 | |
| US2017014481A1 | United States of America | A1 | |
| US2017014482A1 | United States of America | A1 | |
| US2017014545A1 | United States of America | A1 | |
| US2017072107A1 | United States of America | A1 | |
| US2017072108A1 | United States of America | A1 | |
| EP3170505A1 | European Patent Office (EPO) | A1 |
Showing 100 of 113
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 5803356
Titles2
- German
- VON THROMBOZYTEN STAMMENDE WACHSTUMSFAKTORZUSAMMENSETZUNGEN UND ANWENDUNGSVERFAHREN DAFÜR
- English
- GROWTH FACTOR COMPOSITIONS AND APPLICATIONS METHOD THEREOF OF THROMBOCYTES
Classification
- CPC, 30
- A61L27/12
- A61L27/54
- A61K38/18
- A61K9/0063
- A61K38/1858
- A61L27/227
- A61L27/56
- A61L2300/252
- A61L2300/412
- A61F2210/0004
- A61L27/24
- A61L27/40
- A61L27/425
- A61L2300/414
- A61L2400/06
- A61L2430/02
- A61L2430/06
- A61L2430/10
- A61P1/02
- A61P19/00
- A61P19/04
- A61P19/08
- A61F2/28
- A61F2002/2835
- A61K9/14
- A61K38/17
- A61L27/025
- C07K14/49
- A61L27/58
- A61L2430/12
- IPC, 2
- A61K38 00
- C07K14 00